262 related articles for article (PubMed ID: 21147189)
1. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
[TBL] [Abstract][Full Text] [Related]
2. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
4. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
5. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
6. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
[TBL] [Abstract][Full Text] [Related]
7. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
Zhu H; Butera M; Nelson DR; Liu C
Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
[TBL] [Abstract][Full Text] [Related]
8. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
10. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
11. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
Mukherjee A; Di Bisceglie AM; Ray RB
J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
[TBL] [Abstract][Full Text] [Related]
13. HCV NS5A and IRF9 compete for CypA binding.
Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
[TBL] [Abstract][Full Text] [Related]
14. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
[TBL] [Abstract][Full Text] [Related]
15. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
16. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
Lin W; Zhu C; Hong J; Zhao L; Jilg N; Fusco DN; Schaefer EA; Brisac C; Liu X; Peng LF; Xu Q; Chung RT
J Hepatol; 2015 May; 62(5):1024-32. PubMed ID: 25481564
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S
Virol J; 2007 Sep; 4():89. PubMed ID: 17877826
[TBL] [Abstract][Full Text] [Related]
18. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
Yin Y; Romero N; Favoreel HW
J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
[TBL] [Abstract][Full Text] [Related]
19. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.
Zhang Q; Gong R; Qu J; Zhou Y; Liu W; Chen M; Liu Y; Zhu Y; Wu J
J Virol; 2012 Feb; 86(3):1544-54. PubMed ID: 22114332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]